Cite
Screening for celiac disease in Down’s syndrome patients revealed cases of subtotal villous atrophy without typical for celiFac disease HLA-DQ and tissue transglutaminase antibodies
MLA
Raivo Uibo, et al. Screening for Celiac Disease in Down’s Syndrome Patients Revealed Cases of Subtotal Villous Atrophy without Typical for CeliFac Disease HLA-DQ and Tissue Transglutaminase Antibodies. Mar. 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....604f10de812616e565702eded72026f6&authtype=sso&custid=ns315887.
APA
Raivo Uibo, Kaupo Teesalu, Tarvo Sillat, Koit Reimand, Riste Saat, Kaja Metsküla, Tiina Talvik, Tiia Reimand, & Oivi Uibo. (2006). Screening for celiac disease in Down’s syndrome patients revealed cases of subtotal villous atrophy without typical for celiFac disease HLA-DQ and tissue transglutaminase antibodies.
Chicago
Raivo Uibo, Kaupo Teesalu, Tarvo Sillat, Koit Reimand, Riste Saat, Kaja Metsküla, Tiina Talvik, Tiia Reimand, and Oivi Uibo. 2006. “Screening for Celiac Disease in Down’s Syndrome Patients Revealed Cases of Subtotal Villous Atrophy without Typical for CeliFac Disease HLA-DQ and Tissue Transglutaminase Antibodies,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....604f10de812616e565702eded72026f6&authtype=sso&custid=ns315887.